Nuvalent, Inc. recently reported new clinical and preclinical data for its investigational ROS1-selective inhibitor ...
Penguin Books Australia It’s been two years since Caleb Finn released his first anthology of young adult horror stories: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results